2079-50-7

Basic information

• Product Name: Ethanone, 1-[4-[2-(4-morpholinyl)ethoxy]phenyl]-
• CAS NO: 2079-50-7
• Molecular Formula: C14H19NO3
• Molecular Weight: 249.31
• Mol File: 2079-50-7.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: Ethanone, 1-[4-[2-(4-morpholinyl)ethoxy]phenyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: Ethanone, 1-[4-[2-(4-morpholinyl)ethoxy]phenyl]-(2079-50-7)
• EPA Substance Registry System: Ethanone, 1-[4-[2-(4-morpholinyl)ethoxy]phenyl]-(2079-50-7)

Safety Data

• Hazardous Substances Data: 2079-50-7(Hazardous Substances Data)

Usage

General Description

Ethanone, 1-[4-[2-(4-morpholinyl)ethoxy]phenyl]-, also known as Morantel tartrate, is a chemical compound used as an anthelmintic to treat parasitic worm infections in animals. It belongs to the class of organic compounds known as benzene and substituted derivatives, which are aromatic compounds containing one monocyclic ring with no side chains or substituents. Morantel tartrate works by paralyzing and killing the parasites, making it easier for the host's immune system to eliminate them from the body. It is commonly used as a deworming agent for livestock and is only available with a veterinarian's prescription for use in animals.

Upstream product

• 3647-69-6 4-(2-chloroethyl)morpholine hydrochride 
• 99-93-4 4-Hydroxyacetophenone 
• 403-42-9 1-(4-fluorophenyl)ethanone 
• 3240-94-6 N-(2-chlorethyl)morpholine 
• 110-91-8 morpholine 
• 55368-24-6 1-(4-(2-bromoethoxy)phenyl)ethan-1-one 
• 622-40-2 2-(morpholin-4-yl)ethanol 

Downstream Products

• 266679-62-3 1-[4-(2-morpholin-4-yl-ethoxy)-phenyl]-ethanone oxime 
• 908289-07-6 C₁₇H₂₁NO₃S₂ 

Relevant articles and documents

4,6-Diphenylpyrimidine Derivatives as Dual Inhibitors of Monoamine Oxidase and Acetylcholinesterase for the Treatment of Alzheimer's Disease

Alzheimer's disease (AD) is a neurodegenerative disorder with multifactorial pathogenesis. Monoamine oxidase (MAO) and acetylcholinesterase enzymes (AChE) are potential targets for the treatment of AD. A total of 15 new propargyl containing 4,6-diphenylpy

PHENYL-THIAZOLYL INHIBITORS OF PRO-MATRIX METALLOPROTEINASE ACTIVATION

This invention relates to phenyl thiazole I and its therapeutic and prophylactic uses, wherein the variables Rz, Q, J, R1, R3, R5, R6, and R7 are defined in the specification. Disorders treated and/or prevented include rheumatoid arthritis.

Anethole dithiolethione and other dithiolethiones for the treatment of conditions associated with dysfunction of monoamine neruotransmission

The present disclosure relates to dithiolethione derivatives as monoamino oxidase inhibitors, in particular MAO-B inhibitors, to methods for the preparation of these compounds and to novel intermediates useful for the synthesis of said dithiolethiones der